An additional hypothesis posits that facial injection of BoNT/A1 causes structure or function changes in the brain to alleviate depression, possibly by upregulating brain derived neurotrophic factor (BDNF) expression in the brain (França and Lotti, 2017). This evidence concerns the gene BDNF and depressive symptom measurement.